Impact of Retinal Thickness Fluctuations with Ranibizumab Versus Aflibercept in Neovascular Age-Related Macular Degeneration (Salt): 12-Month Results from a Multicentre, Randomised, Phase Iv Trial
AuthID
P-019-NC1
P-019-NC1